April 27, 2018 / 5:35 AM / 3 months ago

BRIEF-Dermapharm Holding FY EBITDA Up At EUR 112.9 Million

April 27 (Reuters) - Dermapharm Holding SE:

* REVENUE IS EXPECTED TO GROW BETWEEN 20-25% YEAR-ON-YEAR IN 2018 WITH ADJUSTED EBITDA UP 22-27%

* REVENUE UP BY 5.1% TO EUR 467.1 MILLION IN FISCAL YEAR 2017 (PREVIOUS YEAR: EUR 444.5 MILLION)

* FY EBITDA AMOUNTED TO EUR 112.9 MILLION (PREVIOUS YEAR: EUR 102.7 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below